Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01336205 · ClinicalTrials.gov registry record · Phase 3
Assessment of Long-term Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Phase 3 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 3
- Development phase
- 844
- Enrollment target
NCT01336205 is a Phase 3 study that has completed, run by AstraZeneca. The registered enrollment target is 844 participants.
The verdict
NCT01336205, a Phase 3 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 844 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the long-term safety and tolerability of NKTR-118 treatment of opioid-induced constipation (OIC) in patients with non-cancer-related pain.
Interventions
- DRUG Usual care
- DRUG NKTR-118
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 844 participants |
| Start Date | 2011-04 |
| Est. Completion | 2012-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01336205
The ClinicalTrials.gov registry entry for NCT01336205 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 844 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual care is the first listed.
NCT01336205 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01336205 about?
NCT01336205 is a clinical study titled "Assessment of Long-term Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation". The purpose of this study is to evaluate the long-term safety and tolerability of NKTR-118 treatment of opioid-induced constipation (OIC) in patients with non-cancer-related pain.
What is the current status of trial NCT01336205?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 844 participants. The study started on 2011-04. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01336205?
The interventions under investigation include: Usual care (DRUG), NKTR-118 (DRUG).
Who is sponsoring clinical trial NCT01336205?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.